News:Business News
Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect
2022-11-29
The educational objectives are:
• Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development
• Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters
Faculty: Dennis Williams
Moderator: Jamie McConaha
More Episodes
Unfit for Recovery: A Chat with Jake Nichols | Pain Pod
2023-03-22
145
2023-03-22
145
TWIRx | Lucky Cost Plus Pharmacy
2023-03-20
468
2023-03-20
468
PUTT’s Pharmacy Legislation Round Up | The PUTTcast
2023-03-18
513
2023-03-18
513
Let’s Talk Stigma Summary
2023-03-13
575
2023-03-13
575
TWIRx | Pharmacists Must Network to Survive
2023-03-10
628
2023-03-10
628
Introducing The Road To Match Day Series | Road To Match Day
2023-03-09
548
2023-03-09
548
FTC Cornering PBMs to Improve Pharmacy Care | PBM Reform
2023-03-07
764
2023-03-07
764
The Expansion of Point of Care Testing | TWIRx
2023-03-06
1.2k
2023-03-06
1.2k
TWIRx | The Innovation in Pharmacy is Accelerating
2023-03-03
914
2023-03-03
914
RxSafe Pharmacy Profit Summit Panel 2023
2023-03-02
758
2023-03-02
758
Integrative Medicine and Sexual Health | SexPharmD
2023-03-01
798
2023-03-01
798
Get this podcast on your
phone, FREE
Create your
podcast in
minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Integrate with iTunes and Google
store - Make money with your podcast
It is Free
